Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COLAL-PRED in Moderate Acute Ulcerative Colitis
NCT00299013Phase 3Completed
- Sponsor
- Alizyme
- Start
- Mar 2006
- Primary completion
- Apr 2008
- Modality
- Orthosteric Ligands
- Countries
- 15
01
Overview
A Phase 3 trial of prednisolone sodium metasulfobenzoate in ulcerative colitis (UC), sponsored by Alizyme. Started Mar 2006; status: completed.
02
Drugs
prednisolone sodium metasulfobenzoate
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT00299013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00299013.